220 related articles for article (PubMed ID: 27930350)
1. Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Liu E; Peter K; Tipping P; Toh BH; Bobik A; Kyaw T
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930350
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
[TBL] [Abstract][Full Text] [Related]
3. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.
Kyaw T; Tay C; Krishnamurthi S; Kanellakis P; Agrotis A; Tipping P; Bobik A; Toh BH
Circ Res; 2011 Sep; 109(8):830-40. PubMed ID: 21868694
[TBL] [Abstract][Full Text] [Related]
4. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
[TBL] [Abstract][Full Text] [Related]
5. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
[TBL] [Abstract][Full Text] [Related]
6. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
7. TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression.
Yin YW; Liao SQ; Zhang MJ; Liu Y; Li BH; Zhou Y; Chen L; Gao CY; Li JC; Zhang LL
Cell Death Dis; 2014 Dec; 5(12):e1574. PubMed ID: 25522268
[TBL] [Abstract][Full Text] [Related]
8. MyD88 but not TLR2, 4 or 9 is essential for IL-12 induction by lactic acid bacteria.
Ichikawa S; Fujii R; Fujiwara D; Komiyama Y; Kaisho T; Sakaguchi M; Konishi Y
Biosci Biotechnol Biochem; 2007 Dec; 71(12):3026-32. PubMed ID: 18071261
[TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
10. Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome.
Kiripolsky J; Romano RA; Kasperek EM; Yu G; Kramer JM
Front Immunol; 2019; 10():2963. PubMed ID: 31993047
[TBL] [Abstract][Full Text] [Related]
11. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
[TBL] [Abstract][Full Text] [Related]
12. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G
Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393
[TBL] [Abstract][Full Text] [Related]
13. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
14. Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin.
Kong X; Wu SH; Zhang L; Chen XQ
Mol Med Rep; 2015 Jul; 12(1):895-904. PubMed ID: 25760938
[TBL] [Abstract][Full Text] [Related]
15. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
[TBL] [Abstract][Full Text] [Related]
16. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity.
Su SB; Silver PB; Grajewski RS; Agarwal RK; Tang J; Chan CC; Caspi RR
J Immunol; 2005 Nov; 175(10):6303-10. PubMed ID: 16272281
[TBL] [Abstract][Full Text] [Related]
17. TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD.
Thorburn AN; Tseng HY; Donovan C; Hansbro NG; Jarnicki AG; Foster PS; Gibson PG; Hansbro PM
PLoS One; 2016; 11(6):e0156402. PubMed ID: 27309732
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
Hirayama T; Tamaki Y; Takakubo Y; Iwazaki K; Sasaki K; Ogino T; Goodman SB; Konttinen YT; Takagi M
J Orthop Res; 2011 Jul; 29(7):984-92. PubMed ID: 21308757
[TBL] [Abstract][Full Text] [Related]
19. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
[TBL] [Abstract][Full Text] [Related]
20. A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells.
Dyevoich AM; Disher NS; Haro MA; Haas KM
Cancer Immunol Immunother; 2020 Oct; 69(10):2113-2124. PubMed ID: 32448982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
